Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 10/20 | 0.67 |
| ▸ | PGK2 | P07205 | 10/20 | 0.67 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.59 |
| ▸ | PTPRB | P23467 | 2/20 | 0.48 |
| ▸ | ACP3 | P15309 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9407120 | 0.92 | PGK1 (0.59) | PGK1PGK2ENPP2PTPRBACP3 | |
| SCHEMBL915744 | 0.89 | PGK1 (0.57) | PGK1PGK2ENPP2PTPRB | |
| SCHEMBL28212706 | 0.89 | PGK1 (0.61) | PGK1PGK2ENPP2PTPRBACP3 | |
| SCHEMBL2574093 | 0.87 | PGK1 (0.55) | PGK1PGK2ENPP2ACP3SMN1; SMN2 | |
| SCHEMBL1486788 | 0.87 | PGK1 (0.59) | PGK1PGK2ENPP2PTPRBACP3 | |
| SCHEMBL532694 | 0.87 | PGK1 (0.55) | PGK1PGK2ENPP2PTPRB | |
| SCHEMBL1823591 | 0.87 | PGK1 (0.55) | PGK1PGK2ENPP2PTPRB | |
| SCHEMBL916912 | 0.87 | PGK1 (0.59) | PGK1PGK2ENPP2SMN1; SMN2 | |
| SCHEMBL3364798 | 0.87 | PGK1 (0.55) | PGK1PGK2ENPP2PTPRBACP3 | |
| SCHEMBL916486 | 0.87 | PGK1 (0.61) | PGK1PGK2ENPP2DGAT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042787-A1 | NEW ULTRA-MICROPOROUS CRYSTALLINE METAL ORGANIC FRAMEWORKS COMPRISING BISPHOSPHONIC ACID LIGANDS | CENTRE NAT RECH SCIENT (FR) | 2026-02-12 | — | — | US | claimed |
| EP-4568979-A1 | NEW ULTRA-MICROPOROUS CRYSTALLINE METAL ORGANIC FRAMEWORKS COMPRISING BISPHOSPHONIC ACID LIGANDS | Centre National de la Recherche Scientifique (FR) | 2025-06-18 | — | — | EP | claimed |
| WO-2024237137-A1 | QUANTUM DOT COMPOSITION, RESIN COMPOSITION, AND WAVELENGTH CONVERSION MATERIAL | 信越化学工業株式会社 | 2024-11-21 | — | — | WO | claimed |
| WO-2024116801-A1 | QUANTUM DOT COMPOSITION, RESIN COMPOSITION USING SAME AND WAVELENGTH CONVERSION MATERIAL | 信越化学工業株式会社 | 2024-06-06 | — | — | WO | claimed |
| WO-2024033100-A1 | NEW ULTRA-MICROPOROUS CRYSTALLINE METAL ORGANIC FRAMEWORKS COMPRISING BISPHOSPHONIC ACID LIGANDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-02-15 | — | — | WO | claimed |
| EP-4321181-A1 | NEW ULTRA-MICROPOROUS CRYSTALLINE METAL ORGANIC FRAMEWORKS COMPRISING BISPHOSPHONIC ACID LIGANDS | Centre national de la recherche scientifique (FR) | 2024-02-14 | — | — | EP | claimed |
| CN-116285946-A | Synthesis method of aluminum quantum dot material with adjustable fluorescence emission | 江苏集萃应用光谱技术研究所有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-114284490-B | Stannous phosphate battery cathode material and preparation method and application thereof | 齐鲁工业大学 | 2023-04-11 | — | — | CN | claimed |
| CN-111672527-B | Molybdenum phosphide catalyst and preparation method thereof | 齐鲁工业大学 | 2022-12-27 | — | — | CN | claimed |
| CN-114284490-A | Stannous phosphate battery negative electrode material and preparation method and application thereof | 齐鲁工业大学 | 2022-04-05 | — | — | CN | claimed |
| EP-0948666-B1 | METHOD FOR TREATING METALLIC SURFACES | CHEMETALL GMBH (DE) | 2003-03-19 | — | — | EP | claimed |
| US-6436475-B1 | PROTECTIVE CORROSION RESISTANT COATING | CHEMETALL GMBH (DE) | 2002-08-20 | — | — | US | claimed |
| WO-2002031065-A2 | METHOD FOR PRETREATING AND SUBSEQUENTLY COATING METALLIC SURFACES WITH A PAINT-TYPE COATING PRIOR TO FORMING AND USE OF SUBSTRATES COATED IN THIS WAY | CHEMETALL GMBH (DE) | 2002-04-18 | — | — | WO | claimed |
| WO-2002031064-A1 | METHOD FOR PRETREATING AND/OR COATING METALLIC SURFACES WITH A PAINT-LIKE COATING PRIOR TO FORMING AND USE OF SUBSTRATES COATED IN THIS WAY | CHEMETALL GMBH (DE) | 2002-04-18 | — | — | WO | claimed |
| WO-2002024344-A2 | METHOD FOR PRETREATING AND COATING METAL SURFACES, PRIOR TO FORMING, WITH A PAINT-LIKE COATING AND USE OF SUBSTRATES SO COATED | CHEMETALL GMBH (DE) | 2002-03-28 | — | — | WO | claimed |
| WO-2001092445-A2 | METHOD FOR TREATING OR PRETREATING CONTAINERS | CHEMETALL GMBH (DE) | 2001-12-06 | — | — | WO | claimed |
| EP-0561948-B1 | PHOSPHONIC ACID DERIVATIVES USEFUL AS ANTIINFLAMMATORY AGENTS | UPJOHN CO (US) | 1995-04-05 | — | — | EP | claimed |
| US-5360797-A | Bisphosphonic acid derivatives useful as anti-arthritic agents | THE UPJOHN COMPANY (US) | 1994-11-01 | — | — | US | claimed |
| EP-0561948-A1 | PHOSPHONIC ACID DERIVATIVES USEFUL AS ANTIINFLAMMATORY AGENTS. | UPJOHN CO (US) | 1993-09-29 | — | — | EP | claimed |
| WO-1992010504-A2 | PHOSPHONIC ACID DERIVATIVES USEFUL AS ANTIINFLAMMATORY AGENTS | THE UPJOHN COMPANY (US) | 1992-06-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042787-A1 | NEW ULTRA-MICROPOROUS CRYSTALLINE METAL ORGANIC FRAMEWORKS COMPRISING BISPHOSPHONIC ACID LIGANDS | SLCO2A1, CXCR2, CXCL10 | PGK1 860/4885PGK2 1164/4885ENPP2 126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.